VIDASAFE MET 50/500 TABLET

Product Description

VIDASAFE MET 50/500 TABLET | Vildagliptin 50mg + Metformin 500mg | Effective Type 2 Diabetes Management

VIDASAFE MET 50/500 TABLET is a potent and reliable pharmaceutical formulation combining Vildagliptin (50mg) and Metformin (500mg), designed to effectively manage blood glucose levels in patients with Type 2 Diabetes Mellitus. This combination therapy offers a synergistic approach, improving glycemic control by enhancing insulin secretion and reducing hepatic glucose production.

Key Benefits:

• Dual-action formula targets insulin resistance and beta-cell dysfunction for superior blood sugar control

• Helps reduce HbA1c levels and maintain stable glucose levels

• Well-tolerated with minimal risk of hypoglycemia when used as prescribed

• Supports weight neutrality or modest weight loss in diabetic patients

• Ideal for use in combination with diet and exercise for comprehensive diabetes management

Usage & Application:
VIDASAFE MET 50/500 TABLET is recommended for adult patients with Type 2 Diabetes who require improved glycemic control when monotherapy is inadequate. It is suitable for distribution to medical retailers, pharmaceutical wholesalers, and bulk buyers focused on diabetes care solutions.

Why Choose VIDASAFE MET 50/500 TABLET?

• Manufactured under stringent quality standards ensuring purity and efficacy

• Available in bulk packaging for seamless supply chain integration

• Trusted formulation by healthcare professionals for managing complex diabetic cases

• Competitive pricing for enhanced profit margins for distributors and retailers